76%
1-year holding
of 25 windows beat the index
Avg / yr+19.6%
Equity: Flexi Cap
MoneyGrow Asset--Bespoke
5.5
Nyra score
Independently scored
3-yr track record · since Apr 2023BlendAUM ₹136 CrSEBI-registered PMS
3Y CAGR
16%
vs 11.3% index
5Y CAGR
—
annualised
Since inception
19.8%
CAGR · net of fees
₹1 Cr became
₹1.72 Cr
index ₹1.42 Cr
AUM
₹136 Cr
strategy size
Minimum
₹50 L
SEBI minimum
Snapshot
What this strategy is
Aim to invest in fundamentally strong companies curated for the investor's specific investment needs.
Performance · what ₹1 crore would have become
₹1.72 Cr
+72% · 1.7× your money
- This strategy₹1.72 Cr
- NSE Multi Asset Index 2 (50:20:20:10)₹1.42 Cr
₹1 Cr invested at inception (Apr 2023)3.0 yrs
Illustrative monthly path, net of fees, modelled to the strategy's since-inception CAGR versus the NSE Multi Asset Index 2 (50:20:20:10). Not the actual NAV series; past performance is not indicative of future returns.
Returns
Trailing returns vs benchmark
Absolute for windows under a year, annualised (CAGR) beyond. Alpha is the strategy minus its benchmark.
1M
3M
6M
1Y
3Y
5Y
SI
This strategy8.6%
43.1%
14.6%
4.7%
16%
—
19.8%
NSE Multi Asset Index 2 (50:20:20:10)
1.7%
7.6%
0.2%
3.5%
11.3%
—
12.3%
Alpha
+6.9%
+35.5%
+14.4%
+1.2%
+4.7%
—
+7.5%
Reliability
How often it has beaten the index
Across every rolling holding period in the modelled history — the longer you hold, the more the odds have favoured the strategy.
100%
3-year holding
of 1 windows beat the index
Avg / yr+19.8%
Computed on an illustrative monthly path modelled to the since-inception CAGR — not the actual NAV series.
Risk
The quality of those returns
Returns mean little without the ride that earned them.
−9.8%
Max drawdown
4.6%
Worst 1-yr window
15.6%
Volatility (ann.)
0.52
Sharpe ratio
A Sharpe of 0.52 means it earned a modest return for each unit of risk taken. Size the position so a drawdown of that order is one you can sit through.
Portfolio
Under the hood — where the money sits
Spread across the market-cap curve.
Market-cap mix
- Cash / Debt100%
Concentration
Holdings—
Cash / debt buffer100%
Top holdings and the sector book stream from the live feed — ask Nyra for the current portfolio.
Manager
Who runs the money
A strategy is only as good as the hand on the wheel.
MG
View full profile Fund manager
Manish Gupta
MoneyGrow Asset--Bespoke · 3-yr strategy tenure · ₹136 Cr managed
Investment philosophy
MoneyGrow Asset--Bespoke's Flexi Cap approach blends valuation discipline with growth conviction, tilting toward whichever side the cycle is paying for. It is benchmarked to the NSE Multi Asset Index 2 (50:20:20:10) but invests with conviction rather than hugging the index.
Conviction over the index
A focused book of roughly 30–40 holdings means the highest-conviction ideas actually move the portfolio.
Through the cycle
A 3-year track record across rallies and drawdowns — positioning shifts with the cycle rather than chasing the last quarter.
Risk first
Drawdowns are managed deliberately; the worst peak-to-trough on record is kept in check.
Nyra's read
A flexi cap strategy with a mixed but improving profile.
Nyra scores MoneyGrow Asset--Bespoke 5.5/10, on a since-inception CAGR near 19.8% and a 3-year CAGR of 16%. Drawdowns have stayed contained — size the position so that ride is one you can hold.
Best suited to
Investors with a 5-year-plus horizon who want active Flexi Cap exposure and can sit through equity drawdowns.
Mind if
A double-digit drawdown would test your nerve, or you need ₹50 L+ to commit at the SEBI minimum.
Pairs well with
A steadier core (large-cap or hybrid) so this can play the higher-conviction satellite in your overall allocation.
Facts & fees
The fine print, in plain sight
- Inception
- Apr 2023
- Track record
- 3 years
- Category
- Equity: Flexi Cap
- Style
- Blend
- Benchmark
- NSE Multi Asset Index 2 (50:20:20:10)
- Holdings
- —
- Fixed fee
- 2.00% fixed
- Performance fee
- Profit share over 10.00% hurdle
- Minimum investment
- ₹50 L
- Lock-in / exit
- Exit Load: 1 Year: 3.00%, 2 Year: 2.00%, 3 Year: 1.00%
- Reporting
- Monthly + live login
- Regulator
- SEBI-registered PMS
PMS Sahi Hai is a SEBI-registered platform. Figures are sourced from the strategy's disclosures and the live feed; the growth chart, rolling-window and risk figures are modelled to the disclosed since-inception CAGR (illustrative, not the actual NAV series). Returns are net of fees where stated. Investments in PMS, AIF and GIFT City strategies are subject to market risk — past performance is not indicative of future results. This page is information, not investment advice.
What investors say
“I held two PMS for four years and couldn't tell you why. One 15-minute review showed me the overlap, the real post-tax number, and one fund worth replacing. Nobody had ever shown me that math.”
Rajesh K.HNI · Mumbai · ₹3.2 Cr · 2 PMS reviewedComposite client stories — names changed, numbers preserved.
FAQ
MoneyGrow Asset--Bespoke — common questions
What is MoneyGrow Asset--Bespoke?
MoneyGrow Asset--Bespoke is a Flexi Cap PMS strategy from MoneyGrow Asset--Bespoke, managed by Manish Gupta. It follows a Blend style, is benchmarked to the NSE Multi Asset Index 2 (50:20:20:10), and carries a Nyra score of 5.5/10.
Who should consider MoneyGrow Asset--Bespoke?
It suits investors with a five-year-plus horizon who want active Flexi Cap exposure and can stay invested through market drawdowns. The SEBI minimum is ₹50 L.
What returns has it delivered?
Since inception (Apr 2023) it has compounded at roughly 19.8% a year, with a 3-year CAGR of 16% against 11.3% for the NSE Multi Asset Index 2 (50:20:20:10). Returns are net of fees; past performance is not a guarantee of future results.
What are the fees and lock-in?
2.00% fixed, with a performance fee of Profit share over 10.00% hurdle. Exit / lock-in terms: Exit Load: 1 Year: 3.00%, 2 Year: 2.00%, 3 Year: 1.00%.
How risky is it?
Like all market-linked products it can fall in value; the worst drawdown on record is disclosed in the factsheet. MoneyGrow Asset--Bespoke is SEBI-registered and reports monthly. This page is information, not investment advice.
